Hao Siyuan, Zhang Xiujuan, Ning Kang, Feng Zehua, Park Soo Yeun, Kuz Cagla Aksu, McFarlin Shane, Richart Donovan, Cheng Fang, Zhang Elizabeth Yan, Zhang-Chen Aaron, Yan Ziying, Qiu Jianming
bioRxiv. 2023 Sep 27:2023.09.27.559795. doi: 10.1101/2023.09.27.559795.
Recombinant (r)AAV2.5T was selected from the directed evolution of an AAV capsid library in human airway epithelium (HAE). The capsid gene of rAAV2.5T is a chimera of the N-terminal unique coding sequence of AAV2 VP1 unique (VP1u) and the VP2- and VP3-coding sequence of AAV5 with a single amino acid mutation of A581T. We conducted two rounds of genome wide CRISPR gRNA library screening for host factors limiting rAAV2.5T transduction in HeLa S3 cells. The screen identified several genes that are critical for rAAV2.5T transduction in HeLa S3 cells, including previously reported genes , , , and , as well as a novel gene . We verified the role of KIAA0319L and WDR63 in rAAV2.5T transduction of polarized HAE by utilizing CRISPR gene knockouts. Although KIAA0319L, a proteinaceous receptor for multiple AAV serotypes, played an essential role in rAAV2.5T transduction of polarized HAE either from apical or basolateral side, our findings demonstrated that the internalization of rAAV2.5T was independent of KIAA0319L. Importantly, we confirmed WDR63 is an important player in rAAV2.5T transduction of HAE, while not being involved in vector internalization and nuclear entry. Furthermore, we identified that the basal stem cells of HAE can be significantly transduced by rAAV2.5T.
The essential steps of a successful gene delivery by rAAV include vector internalization, intracellular trafficking, nuclear import, uncoating, double-stranded (ds)DNA conversion, and transgene expression. rAAV2.5T has a chimeric capsid of AAV2 VP1u and AAV5 VP2 and VP3 with the mutation A581T. Our investigation revealed that KIAA0319L, the multiple AAV serotype receptor, is not essential for vector internalization but remains critical for efficient vector transduction to human airway epithelia. Additionally, we identified that a novel gene , whose cellular function is not well understood, plays an important role in vector transduction of human airway epithelia but not vector internalization and nuclear entry. Our study also discovered the substantial transduction potential of rAAV2.5T in basal stem cells of human airway epithelia, underscoring its utility in gene editing of human airways. Thus, the knowledge derived from this study holds promise for the advancement of gene therapy in the treatment of pulmonary genetic diseases.
重组(r)AAV2.5T是从人呼吸道上皮(HAE)中AAV衣壳文库的定向进化中筛选出来的。rAAV2.5T的衣壳基因是AAV2 VP1独特区(VP1u)的N端独特编码序列与AAV5的VP2和VP3编码序列的嵌合体,有一个A581T的单氨基酸突变。我们在HeLa S3细胞中进行了两轮全基因组CRISPR gRNA文库筛选,以寻找限制rAAV2.5T转导的宿主因子。该筛选鉴定出了几个对HeLa S3细胞中rAAV2.5T转导至关重要的基因,包括先前报道的基因 、 、 、 ,以及一个新基因 。我们利用CRISPR基因敲除验证了KIAA0319L和WDR63在极化HAE的rAAV2.5T转导中的作用。尽管KIAA0319L是多种AAV血清型的蛋白质受体,在极化HAE从顶端或基底外侧的rAAV2.5T转导中起重要作用,但我们的研究结果表明rAAV2.5T的内化不依赖于KIAA0319L。重要的是,我们证实WDR63是HAE的rAAV2.5T转导中的一个重要参与者,而不参与载体内化和核进入。此外,我们发现HAE的基底干细胞可被rAAV2.5T有效转导。
rAAV成功进行基因递送的关键步骤包括载体内化、细胞内运输、核输入、脱壳、双链(ds)DNA转化和转基因表达。rAAV2.5T具有AAV2 VP1u和AAV5 VP2及VP3的嵌合衣壳,并带有A581T突变。我们的研究表明,多种AAV血清型受体KIAA0319L对载体内化并非必不可少,但对高效载体转导至人呼吸道上皮细胞仍然至关重要。此外,我们鉴定出一个细胞功能尚不清楚的新基因 在人呼吸道上皮细胞的载体转导中起重要作用,但不参与载体内化和核进入。我们的研究还发现rAAV2.5T在人呼吸道上皮基底干细胞中具有显著的转导潜力,突出了其在人类气道基因编辑中的效用。因此,本研究获得的知识有望推动肺部遗传疾病治疗中的基因治疗进展。